{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T09:52:43Z","timestamp":1760953963323},"publisher-location":"New York, NY","reference-count":66,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493978984"},{"type":"electronic","value":"9781493978991"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-1-4939-7899-1_16","type":"book-chapter","created":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T15:27:16Z","timestamp":1529681236000},"page":"327-345","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Computational Approaches in Multitarget Drug Discovery"],"prefix":"10.1007","author":[{"given":"Luciana","family":"Scotti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamilton Mitsugu","family":"Ishiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo Cavalcante","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiago Branquinho","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus T.","family":"Scotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,23]]},"reference":[{"issue":"7","key":"16_CR1","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1001\/jama.296.7.827","volume":"296","author":"SM Hammer","year":"2006","unstructured":"Hammer SM, Abergh AJ, Erro JJ et al (2006) Treatment for Adult HIV Infection. JAMA 296(7):410\u2013425","journal-title":"JAMA"},{"key":"16_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.sbi.2006.01.013","volume":"16","author":"AL Hopkins","year":"2006","unstructured":"Hopkins AL, Mason JS, Overington JP (2006) Can we rationally design promiscuous drugs? Curr Opin Struct Biol 16:127. Available on: \nhttp:\/\/www.sciencedirect.com\/science\/article\/pii\/S0959440X06000157\n\n. Access 20 October, 2017","journal-title":"Curr Opin Struct Biol"},{"issue":"2","key":"16_CR3","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.tips.2007.11.007","volume":"29","author":"E Jenwitheesuk","year":"2008","unstructured":"Jenwitheesuk E, Horst AJ, Rivas KL, Van Voorhis WC, Samudrala R (2008) Novel paradigms for drug discovery: computational multitarget screening. Trends Pharmacol Sci 29(2):62\u201371","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"16_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1472-6807-3-2","volume":"3","author":"E Jenwitheesuk","year":"2003","unstructured":"Jenwitheesuk E, Samudrala R (2003) Improved prediction of HIV-1 protease-inhibitor binding energies by molecular dynamics simulations. BMC Struct Biol 3(1):2","journal-title":"BMC Struct Biol"},{"issue":"12","key":"16_CR5","first-page":"1490","volume":"294","author":"E Jenwitheesuk","year":"2005","unstructured":"Jenwitheesuk E, Samudrala R (2005) Identification of potential multitarget antimalarial drugs. JAMA 294(12):1490\u20131491","journal-title":"JAMA"},{"issue":"8","key":"16_CR6","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1258\/095646206778145587","volume":"17","author":"R Jones","year":"2006","unstructured":"Jones R, Gazzard B (2006) The cost of antiretroviral drugs and influence on prescribing policies. Int J STD AIDS 17(8):499\u2013506","journal-title":"Int J STD AIDS"},{"issue":"6","key":"16_CR7","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1097\/QAD.0b013e3280121ac6","volume":"21","author":"KJ Metzner","year":"2007","unstructured":"Metzner KJ, Allers K, Rauch P, Harrer T (2007) Rapid selection of drug-resistant HIV-1 during the first months of suppressive ART in treatment-naive patients. AIDS 21(6):703\u2013711","journal-title":"AIDS"},{"issue":"5","key":"16_CR8","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1021\/jm000290u","volume":"44","author":"KC Santhosh","year":"2001","unstructured":"Santhosh KC, Paul GC, De Clercq E, Pannecouque C, Witvrouw M, Loftus TL, Turpin JA, Buckheit RW Jr, Cushman M (2001) Correlation of anti-HIV activity with anion spacing in a series of cosalane analogues with extended polycarboxylate pharmacophores. J Med Chem 44(5):703\u2013714","journal-title":"J Med Chem"},{"issue":"5","key":"16_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.0010049","volume":"1","author":"ED Scheeff","year":"2005","unstructured":"Scheeff ED, Bourne PE (2005) Structural evolution of the protein kinase\u2013like superfamily. PLoS Comput Biol 1(5):e49","journal-title":"PLoS Comput Biol"},{"issue":"7019","key":"16_CR10","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nature03197","volume":"432","author":"BK Shoichet","year":"2005","unstructured":"Shoichet BK (2005) Virtual screening of chemical libraries. Nature 432(7019):862\u2013865","journal-title":"Nature"},{"issue":"7","key":"16_CR11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1056\/NEJM199508173330701","volume":"333","author":"PA Volberding","year":"1995","unstructured":"Volberding PA, Lagakos SW, Grimes JM, Stein DS, Rooney J, Meng TC, Fischl MA, Collier AC, Phair JP, Hirsch MS (1995) A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. N Engl J Med 333(7):401\u2013407","journal-title":"N Engl J Med"},{"key":"16_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0014-5793(01)02236-0","volume":"492","author":"RK Wierenga","year":"2001","unstructured":"Wierenga RK (2001) The TIM-barrel fold: a versatile framework for efficient enzymes. FEBS Lett 492:193. Available on http:\/\/doi.wiley.com\/10.1016\/S0014-5793%2801%2902236-0. Access 9 October, 2017","journal-title":"FEBS Lett"},{"issue":"33","key":"16_CR13","doi-asserted-by":"publisher","first-page":"11556","DOI":"10.1021\/ja504810z","volume":"136","author":"J Pei","year":"2014","unstructured":"Pei J, Yin N, Ma X, Lai L (2014) Systems biology brings new dimensions for structure-based drug design. J Am Chem Soc 136(33):11556\u201311565","journal-title":"J Am Chem Soc"},{"issue":"5","key":"16_CR14","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.coph.2008.06.008","volume":"8","author":"H Br\u00f6tz-Oesterhelt","year":"2008","unstructured":"Br\u00f6tz-Oesterhelt H, Brunner NA (2008) How many modes of action should an antibiotic have? Curr Opin Pharmacol 8(5):564\u2013573","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"16_CR15","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nrc2787","volume":"10","author":"ZA Knight","year":"2010","unstructured":"Knight ZA, Lin H, Shokat KM (2010) Targeting the cancer kinome through polypharmacology. Nat Rev Cancer 10(2):130\u2013137","journal-title":"Nat Rev Cancer"},{"issue":"05","key":"16_CR16","first-page":"10","volume":"03","author":"R Kumar","year":"2016","unstructured":"Kumar R, Sharma A, Tiwari RK (2016) Computational drug designing and development: an insight. IRJET 03(05):10\u201314","journal-title":"IRJET"},{"key":"16_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/930354","volume":"2013","author":"MN Jadhav","year":"2013","unstructured":"Jadhav MN, Kokil GR, Harak SS, Wagh SB (2013) Direct and indirect drug design approaches for the development of novel tricyclic antipsychotics: potential 5-HT2A antagonist. J Chem 2013:1\u201310","journal-title":"J Chem"},{"issue":"7","key":"16_CR18","doi-asserted-by":"publisher","first-page":"572","DOI":"10.2174\/1386207319666160420141200","volume":"19","author":"IG Shibi","year":"2016","unstructured":"Shibi IG, Aswathy L, Jisha RS, Masand VH, Gajbhiye JM (2016) Virtual Screening Techniques to Probe the Antimalarial Activity of some Traditionally Used Phytochemicals. Comb Chem High Throughput Screen 19(7):572\u2013591","journal-title":"Comb Chem High Throughput Screen"},{"issue":"Web Server issu","key":"16_CR19","doi-asserted-by":"publisher","first-page":"W623","DOI":"10.1093\/nar\/gkp456","volume":"37","author":"Y Wang","year":"2009","unstructured":"Wang Y, Xiao J, Suzek TO, Zhang J, Wang J, Bryant SH (2009) PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res 37(Web Server issue):W623\u2013W633","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"16_CR20","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1021\/ci049847v","volume":"45","author":"K Liu","year":"2005","unstructured":"Liu K, Feng J, Young SS (2005) PowerMV:a software environment for molecular viewing.; descriptor generation.; data analysis and hit evaluation. J Chem Inf Model 45(2):515\u2013522","journal-title":"J Chem Inf Model"},{"key":"16_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jmgm.2014.02.006","volume":"50","author":"M Kumar","year":"2014","unstructured":"Kumar M, Makhal B, Gupta VK, Sharma A (2014) In silico investigation of medicinal spectrum of imidazo-azines from the perspective of multitarget screening against malaria, tuberculosis and Chagas disease. J Mol Graph Model 50:1\u20139","journal-title":"J Mol Graph Model"},{"issue":"5","key":"16_CR22","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nsb921","volume":"10","author":"J Yuvaniyama","year":"2003","unstructured":"Yuvaniyama J, Chitnumsub P, Kamchonwongpaisan S, Vanichtanankul J, Sirawaraporn W, Taylor P, Walkinshaw MD, Yuthavong Y (2003) Insights into antifo- late resistance from malarial DHFR-TS structures. Nat Struct Biol 10(5):357\u2013365","journal-title":"Nat Struct Biol"},{"issue":"15","key":"16_CR23","doi-asserted-by":"publisher","first-page":"13106","DOI":"10.1074\/jbc.M112000200","volume":"277","author":"R Perozzo","year":"2002","unstructured":"Perozzo R, Kuo M, Sidhu AB, Valiyaveettil JT, Bittman R, Jacobs WR Jr, Fidock DA, Sacchettini JC (2002) Structural elucidation of the specificity of the antibacterial agent triclosan for malarial triclosan for malarial enoyl acyl carrier protein reductase. J Biol Chem 277(15):13106\u201313114","journal-title":"J Biol Chem"},{"issue":"2","key":"16_CR24","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.str.2007.11.014","volume":"16","author":"A Merckx","year":"2008","unstructured":"Merckx A, Echalier A, Langford K, Sicard A, Langsley G, Joore J, Doerig C, Noble M, Endicott J (2008) Structures of P. falciparum protein kinase 7 identify an activation motif and leads for inhibitor design. Structure 16(2):228\u2013238","journal-title":"Structure"},{"key":"16_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1107\/S1744309106046823","volume":"63","author":"MV Dias","year":"2007","unstructured":"Dias MV, Faim LM, Vasconcelos IB, De Oliveira JS, Basso LA, Santos DS, De Azevedo W (2007) Structure of shikimate kinase from Mycobacterium tuberculosis complexed with ADP and shikimate at 1.9\u00a0\u00c5 of resolution. Acta Crystallogr Sect F 63:1\u20136","journal-title":"Acta Crystallogr Sect F"},{"issue":"5","key":"16_CR26","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1110\/ps.0241803","volume":"12","author":"S Wang","year":"2003","unstructured":"Wang S, Eisenberg D (2003) Crystal structures of a pantothenate synthetase from M. tuberculosis and its complexes with substrates and a reaction intermediate. Protein Sci 12(5):1097\u20131108","journal-title":"Protein Sci"},{"issue":"1","key":"16_CR27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1006\/jmbi.2001.4843","volume":"311","author":"I Li de la Sierra","year":"2001","unstructured":"Li de la Sierra I, Munier-Lehmann H, Gilles AM, B\u00e2rzu O, Delarue M (2001) X-ray structure of TMP kinase from Mycobacterium tuberculosis complexed with TMP at 1.95\u00a0\u00c5 resolution. J Mol Biol 311(1):87\u2013100","journal-title":"J Mol Biol"},{"issue":"1","key":"16_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.tube.2009.10.007","volume":"90","author":"C Basavannacharya","year":"2010","unstructured":"Basavannacharya C, Robertson G, Munshi T, Keep NH, Bhakta S (2010) ATP- dependent MurE ligase in Mycobacterium tuberculosis: biochemical and structural characterisation. Tuberculosis 90(1):16\u201324","journal-title":"Tuberculosis"},{"issue":"1","key":"16_CR29","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0969-2126(99)80011-2","volume":"7","author":"CS Bond","year":"1999","unstructured":"Bond CS, Zhang Y, Berriman M, Cunningham ML, Fairlamb AH, Hunter WN (1999) Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors. Structure 7(1):81\u201389","journal-title":"Structure"},{"issue":"22","key":"16_CR30","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.1046\/j.1432-1033.2003.03857.x","volume":"270","author":"S Ladame","year":"2003","unstructured":"Ladame S, Castilho MS, Silva CH, Denier C, Hannaert V, P\u00e9ri\u00e9 J, Oliva G, Willson M (2003) Crystal structure of Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase complexed with an analogue of 1,3-bisphospho-d-glyceric acid. Eur J Biochem 270(22):4574\u20134586","journal-title":"Eur J Biochem"},{"issue":"5","key":"16_CR31","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.str.2004.02.036","volume":"12","author":"MF Amaya","year":"2004","unstructured":"Amaya MF, Watts AG, Damager I, Wehenkel A, Nguyen T, Buschiazzo A, Paris G, Frasch AC, Withers SG, Alzari PM (2004) Structural insights into the catalytic mechanism of Trypanosoma cruzi trans-sialidase. Structure 12(5):775\u2013784","journal-title":"Structure"},{"issue":"7","key":"16_CR32","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S1359-6446(05)03386-6","volume":"10","author":"C Abad-zapatero","year":"2005","unstructured":"Abad-zapatero C, Metz JT (2005) Ligand efficiency indices as guideposts for drug Discovery. Drug Discov Today 10(7):464\u2013469","journal-title":"Drug Discov Today"},{"issue":"3-4","key":"16_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3109\/0954898X.2016.1146416","volume":"26","author":"F Azam","year":"2015","unstructured":"Azam F, Mohamed N, Alhussen F (2015) Molecular interaction studies of green tea catechins as multitarget drug candidates for the treatment of Parkinson\u2019s disease: computational and structural insights. Network 26(3-4):97\u2013115","journal-title":"Network"},{"issue":"3","key":"16_CR34","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1016\/j.foodchem.2013.05.122","volume":"141","author":"C Braicu","year":"2013","unstructured":"Braicu C, Ladomery MR, Chedea VS, Irimie A, Berindan-Neagoe I (2013) The relationship between the structure and biological actions of green tea catechins. Food Chem 141(3):3282\u20133289","journal-title":"Food Chem"},{"issue":"5","key":"16_CR35","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.freeradbiomed.2005.04.022","volume":"39","author":"S Guo","year":"2005","unstructured":"Guo S, Bezard E, Zhao B (2005) Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis through ROS-NO pathway. Free Radic Biol Med 39(5):682\u2013695","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"16_CR36","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1016\/j.bmc.2016.04.041","volume":"24","author":"M Maqbool","year":"2016","unstructured":"Maqbool M, Manral A, Jameel E, Kumar J, Saini V, Shandilya A, Tiwari M, Hoda N, Jayaram B (2016) Development of cyanopyridine-triazine hybrids as lead multitarget anti-Alzheimer agents. Bioorg Med Chem 24(12):2777\u20132788","journal-title":"Bioorg Med Chem"},{"issue":"139","key":"16_CR37","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.ejmech.2017.08.021","volume":"9","author":"D Palanimuthu","year":"2017","unstructured":"Palanimuthu D, Poon R, Sahni S, Anjum R, Hibbs D, Lin HY, Bernhardt PV, Kalinowski DS, Richardson DR (2017) A novel class of thiosemicarbazones show multi-functional activity for the treatment of Alzheimer\u2019s disease. Eur J Med Chem 9(139):612\u2013632","journal-title":"Eur J Med Chem"},{"issue":"3","key":"16_CR38","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrd1330","volume":"3","author":"KJ Barnham","year":"2004","unstructured":"Barnham KJ, Masters CL, Bush AI (2004) Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 3(3):205\u2013214","journal-title":"Nat Rev Drug Discov"},{"key":"16_CR39","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.freeradbiomed.2012.10.558","volume":"62","author":"S Ayton","year":"2013","unstructured":"Ayton S, Lei P, Bush AI (2013) Metallostasis in Alzheimer\u2019s disease. Free Radic Biol Med 62:76\u201389","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"16_CR40","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3233\/JAD-2009-1068","volume":"17","author":"ML Hegde","year":"2009","unstructured":"Hegde ML, Bharathi P, Suram A, Venugopal C, Jagannathan R, Poddar P, Srinivas P, Sambamurti K, Rao KJ, Scancar J, Messori L, Zecca L, Zatta P (2009) Challenges associated with metal chelation therapy in Alzheimer\u2019s disease. J Alzheimers Dis 17(3):457\u2013468","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"16_CR41","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0301-0082(99)00023-4","volume":"60","author":"JC Vickers","year":"2000","unstructured":"Vickers JC, Dickson TC, Adlard PA, Saunders HL, King CE, McCormack G (2000) The cause of neuronal degeneration in Alzheimer\u2019s disease. Prog Neurobiol 60(2):139\u2013165","journal-title":"Prog Neurobiol"},{"issue":"12","key":"16_CR42","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1111\/ejn.12169","volume":"37","author":"DM Wolfe","year":"2013","unstructured":"Wolfe DM, Lee JH, Kumar A, Lee S, Orenstein SJ, Nixon RA (2013) Autophagy failure in Alzheimer\u2019s disease and the role of defective lysosomal acidification. Eur J Neurosci 37(12):1949\u20131961","journal-title":"Eur J Neurosci"},{"issue":"4","key":"16_CR43","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1021\/jm901132v","volume":"53","author":"R Morphy","year":"2010","unstructured":"Morphy R (2010) Selectively nonselective kinase inhibition: striking the right balance. J Med Chem 53(4):1413\u20131437","journal-title":"J Med Chem"},{"issue":"11","key":"16_CR44","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1021\/cb4003283","volume":"8","author":"MP Martin","year":"2013","unstructured":"Martin MP, Olesen SH, Georg GI, Sch\u00f6nbrunn E (2013) Cyclin-dependent kinase inhibitor dinaciclib interacts with the acetyl-lysine recognition site of bromodomains. ACS Chem Biol 8(11):2360\u20132365","journal-title":"ACS Chem Biol"},{"issue":"8","key":"16_CR45","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1158\/1535-7163.MCT-10-0324","volume":"9","author":"D Parry","year":"2010","unstructured":"Parry D, Guzi T, Shanahan F, Davis N, Prabhavalkar D, Wiswell D, Seghezzi W, Paruch K, Dwyer MP, Doll R, Nomeir A, Windsor W, Fischmann T, Wang Y, Oft M, Chen T, Kirschmeier P, Lees EM (2010) Dinaciclib (SCH 727965), a novel and potent cyclin-dependent kinase inhibitor. Mol Cancer Ther 9(8):2344\u20132353","journal-title":"Mol Cancer Ther"},{"issue":"20","key":"16_CR46","doi-asserted-by":"publisher","first-page":"9305","DOI":"10.1021\/acs.jmedchem.6b00438","volume":"59","author":"L Carlino","year":"2016","unstructured":"Carlino L, Rastelli G (2016) Dual kinase-bromodomain inhibitors in anticancer drug discovery: a structural and pharmacological perspective. J Med Chem 59(20):9305\u20139320","journal-title":"J Med Chem"},{"issue":"10-11","key":"16_CR47","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10822-006-9087-6","volume":"20","author":"SL Dixon","year":"2006","unstructured":"Dixon SL, Smondyre AM, Knoll EH, Rao SN, Shaw DE, Friesner RA (2006) PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. J Comput Aided Mol Des 20(10-11):647\u2013671","journal-title":"J Comput Aided Mol Des"},{"issue":"5","key":"16_CR48","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/j.1747-0285.2006.00384.x","volume":"67","author":"SL Dixon","year":"2006","unstructured":"Dixon SL, Smondyrev AM, Rao SN (2006) PHASE: a novel approach to pharmacophore modeling and 3D database searching. Chem Biol Drug Des 67(5):370\u2013372","journal-title":"Chem Biol Drug Des"},{"key":"16_CR49","doi-asserted-by":"publisher","first-page":"16924","DOI":"10.1038\/srep16924","volume":"05","author":"BK Allen","year":"2015","unstructured":"Allen BK, Mehta S, Ember SWJ, Schonbrunn E, Ayad N, Sch\u00fcrer SC (2015) Large-scale computational screening identifies first in class multitarget inhibitor of EGFR kinase and BRD4. Sci Rep 05:16924","journal-title":"Sci Rep"},{"issue":"1","key":"16_CR50","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1021\/ci300403k","volume":"53","author":"SC Sch\u00fcrer","year":"2013","unstructured":"Sch\u00fcrer SC, Muskal SM (2013) Kinome-wide activity modeling from diverse public high-quality data sets. J Chem Inf Model 53(1):27\u201338","journal-title":"J Chem Inf Model"},{"issue":"Database issue","key":"16_CR51","doi-asserted-by":"publisher","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","volume":"40","author":"A Gaulton","year":"2012","unstructured":"Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP (2012) Chembl: a large-scale bioactivity database for drug discovery. Nucleic Acids Res 40(Database issue):D1100\u2013D1107","journal-title":"Nucleic Acids Res"},{"issue":"23","key":"16_CR52","doi-asserted-by":"publisher","first-page":"6789","DOI":"10.1021\/jm0608356","volume":"49","author":"N Huang","year":"2006","unstructured":"Huang N, Shoichet BK, Irwin JJ (2006) Benchmarking sets for molecular docking. J Med Chem 49(23):6789\u20136801","journal-title":"J Med Chem"},{"issue":"8","key":"16_CR53","doi-asserted-by":"publisher","first-page":"4760","DOI":"10.1021\/acsomega.7b00553","volume":"2","author":"BK Allen","year":"2017","unstructured":"Allen BK, Mehta S, Ember SWJ, Zhu JY, Sch\u00f6nbrunn E, Ayad NG, Sch\u00fcrer SC (2017) Identification of a novel class of BRD4 inhibitors by computational screening and binding simulations. ACS Omega 2(8):4760\u20134771","journal-title":"ACS Omega"},{"issue":"3","key":"16_CR54","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.nantod.2012.04.003","volume":"7","author":"AC Engler","year":"2016","unstructured":"Engler AC, Wiradharma N, Ong ZY, Coady DJ, Hedrick JL, Yang YY (2016) Emerging trends in macromolecular antimicrobials to fight multi-drug-resistant infections. Nano Today 7(3):201\u2013222","journal-title":"Nano Today"},{"key":"16_CR55","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1021\/acs.jcim.5b00630","volume":"56","author":"A Speck-Planche","year":"2016","unstructured":"Speck-Planche A, Kleandrova VV, Ruso JM, Cordeiro MN (2016) First multitarget chemo-bioinformatic model to enable the discovery of antibacterial peptides against multiple gram-positive pathogens. J Chem Inf Model 56:588\u2013598","journal-title":"J Chem Inf Model"},{"key":"16_CR56","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1128\/CMR.00056-05","volume":"19","author":"H Jenssen","year":"2006","unstructured":"Jenssen H, Hamill P, Hancock RE (2006) Peptide antimicrobial agents. Clin Microbiol Rev 19:491\u2013511","journal-title":"Clin Microbiol Rev"},{"key":"16_CR57","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrmicro1098","volume":"3","author":"KA Brogden","year":"2005","unstructured":"Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3:238\u2013250","journal-title":"Nat Rev Microbiol"},{"key":"16_CR58","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/1574-6968.12489","volume":"357","author":"G Gogoladze","year":"2014","unstructured":"Gogoladze G, Grigolava M, Vishnepolsky B, Chubinidze M, Duroux P, Lefranc MP, Pirtskhalava M (2014) DBAASP: database of antimicrobial activity and structure of peptides. FEMS Microbiol Lett 357:63\u201368","journal-title":"FEMS Microbiol Lett"},{"key":"16_CR59","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.syapm.2013.11.002","volume":"37","author":"B Verslyppe","year":"2014","unstructured":"Verslyppe B, De Smet W, De Baets B, De Vos P, Dawyndt P (2014) Straininfo introduces electronic passports for microorganisms. Syst Appl Microbiol 37:42\u201350","journal-title":"Syst Appl Microbiol"},{"key":"16_CR60","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1007\/s00216-010-3485-2","volume":"396","author":"S Dresen","year":"2010","unstructured":"Dresen S, Ferreir\u00f3s N, Gnann H, Zimmermann R, Weinmann W (2010) Detection and identification of 700 drugs by multi-target screening with a 3200 Q TRAP\u00ae LC-MS\/MS system and library searching. Anal Bioanal Chem 396:2425\u20132434","journal-title":"Anal Bioanal Chem"},{"key":"16_CR61","doi-asserted-by":"publisher","first-page":"5957","DOI":"10.1111\/febs.12268","volume":"280","author":"DB Kell","year":"2013","unstructured":"Kell DB (2013) Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it. FEBS J 280:5957\u20135980","journal-title":"FEBS J"},{"key":"16_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1000648","volume":"6","author":"JD Durrant","year":"2010","unstructured":"Durrant JD, Amaro RE, Xie L, Urbaniak MD, Ferguson MAJ, Haapalainen A et al (2010) A multidimensional strategy to detect polypharmacological targets in the absence of structural and sequence homology (2010). PLoS Comput Biol 6:e1000648","journal-title":"PLoS Comput Biol"},{"key":"16_CR63","first-page":"1","volume":"2012","author":"H Ouyang","year":"2012","unstructured":"Ouyang H, Liu S, Zeng W, Levitt RC, Candiotti KA, Hao S (2012) An emerging new paradigm in opioid withdrawal: a critical role for glia-neuron signaling in the periaqueductal gray. Sci World J 2012:1\u20139","journal-title":"Sci World J"},{"key":"16_CR64","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1021\/ml400232p","volume":"4","author":"F Bello Del","year":"2013","unstructured":"Del Bello F, Diamanti E, Giannella M, Mammoli V, Mattioli L, Titomanlio F (2013) Exploring multitarget interactions to reduce opiate withdrawal syndrome and psychiatric comorbidity. ACS Med Chem Lett 4:875\u2013879","journal-title":"ACS Med Chem Lett"},{"key":"16_CR65","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ctim.2012.12.001","volume":"21","author":"S Ma","year":"2013","unstructured":"Ma S, Feng C, Zhang X, Dai G, Li C, Cheng X et al (2013) The multi-target capabilities of the compounds in a TCM used to treat sepsis and their in silico pharmacology. Complement Ther Med 21:35\u201341","journal-title":"Complement Ther Med"},{"key":"16_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1039\/c2mb90048c","volume":"9","author":"S Gu","year":"2013","unstructured":"Gu S, Yin N, Pei J, Lai L (2013) Understanding molecular mechanisms of traditional Chinese medicine for the treatment of influenza viruses infection by computational approaches. Mol Biosyst 9:1\u20135","journal-title":"Mol Biosyst"}],"container-title":["Methods in Molecular Biology","Computational Toxicology"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-7899-1_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T15:36:54Z","timestamp":1529681814000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-7899-1_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9781493978984","9781493978991"],"references-count":66,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-7899-1_16","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2018]]}}}